| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
7 companies
Thompson Peter A. is a Director, 10% Owner at PMVP with holdings across 7 companies. Recent SEC Form 4 filings include 3 buys and 17 sells.
Estimated insider holdings value: $128.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 27, 2026 | SION Sionna Therapeutics, Inc. | Director | Sell | 101 | $44.49 | $4,493.49 | - | - | - | |
| May 11, 2026 | SION Sionna Therapeutics, Inc. | Director | Sell | 292,952 | $45.62 | $13,364,064.50 | -3.4% | - | - | |
| Apr 18, 2026 | SION Sionna Therapeutics, Inc. | Director | Sell | 55,345 | $44.67 | $2,472,342.92 | -0.9% | - | - | |
| Apr 16, 2026 | SION Sionna Therapeutics, Inc. | Director | Sell | 510,583 | $44.94 | $22,945,043.50 | -5.0% | - | - | |
| Dec 24, 2025 | SION Sionna Therapeutics, Inc. | Director | Sell | 33,356 | $44.55 | $1,486,009.80 | -0.9% | -21.0% | - | |
| Dec 19, 2025 | SION Sionna Therapeutics, Inc. | Director | Sell | 1,875 | $44.49 | $83,427.75 | - | -16.2% | - | |
| Nov 26, 2025 | SION Sionna Therapeutics, Inc. | Director | Sell | 108,073 | $44.55 | $4,814,204.82 | -1.0% | -14.8% | - | |
| Jun 27, 2025 | CRVS Corvus Pharmaceuticals, Inc. | Director, 10% Owner | Sell | 1,176,332 | $4.16 | $4,891,894.26 | -14.1% | +69.9% | - | |
| Apr 3, 2025 | EWTX Edgewise Therapeutics, Inc. | Director, 10% Owner | Buy | 496,771 | $20.13 | $10,000,000.23 | +3.4% | -4.2% | +145.4% | |
| Feb 10, 2025 | SION Sionna Therapeutics, Inc. | Director | Buy | 550,000 | $18.00 | $9,900,000.00 | +17.4% | -42.0% | +70.9% |